hero image

Holmes Named Next-Generation Pharmacist Awards Finalist

Published on 23 September 2020

Kendra Holmes, B.S. ’99, Pharm.D. ’00, senior vice president of Affinia Healthcare and secretary of the University of Health Sciences and Pharmacy in St. Louis Board of Trustees, has been recognized by Pharmacy Times and Parata Systems as a 2020 Next-Generation Pharmacist® Awards finalist.

Each year, the awards program, which is sponsored by Pharmacy Times in conjunction with Parata Systems, recognizes 30 exceptional pharmacy professionals nationwide in 10 categories.

Holmes has been selected as a finalist in the Patient Care category. Finalists in the category have established themselves as exemplary patient advocates through their dedicated focus on patient care and customer service.

Over the past 17 years, Holmes has worked tirelessly to address health disparities in the St. Louis area by ensuring that residents in some of the region’s most vulnerable communities have access to high quality health care services.

Rising through the ranks at Affinia Healthcare from staff pharmacist to her current role as senior vice president, Holmes’ accomplishments have included integrating mammography and radiology services at Affinia locations and implementing an in-house moderate complexity testing laboratory with the capacity to handle a variety of point-of-care testing services including tests for glucose, infectious diseases, hypertension, liver function and strep.

She has also worked to ensure that underserved populations have affordable access to substance abuse treatment by partnering with St. Louis City and County to create a medication-assisted treatment program that provides treatment for addiction and ongoing access to critical mental health services. Holmes also serves as chair of St. Louis County’s Prosecutor Lead Diversion Advisory Committee, which works to connect first-time and low-level offenders with appropriate substance abuse treatment resources and provide life-skills training designed to direct individuals away from incarceration and into treatment programs.

In recent months, Holmes worked to provide underserved patients with free access to COVID-19 testing. In partnership with the St. Louis Regional Health Commission, Affinia Healthcare established the first COVID-19 testing station in North St. Louis City in early April. In the weeks following, four additional stations were established in North St. Louis City, North St. Louis County and South St. Louis City. In total, the five stations collectively tested more than 6,000 area residents during April and May. In recent weeks, Affinia has also worked with the Missouri Department of Health and Senior Services to provide mobile testing in COVID-19 “hot spot” locations across the St. Louis area. Since its testing efforts began this spring, Affinia Healthcare has tested over 14,000 St. Louis residents for COVID-19.

“I’m honored to have been selected as a Next-Generation Pharmacist finalist,” Holmes said. “I love the work that I do, and it’s really special that my work has been recognized in this way.”

The 2020 Next-Generation Pharmacist® Awards program is peer-nominated and honors remarkable pharmacists, student pharmacists, technicians and industry advocates from a range of pharmacy practice settings including large chain retailers, independent pharmacies, specialty pharmacies, military bases, health clinics and educational institutions.

Finalists will be formally recognized during a virtual event on Oct. 21. During the event, the winners in each category will be announced, and one winner will be named the 2020 Next-Generation Pharmacist®. All finalists will also be featured in the September issue of Pharmacy Times and online at pharmacytimes.com.

Additional information and the full list of finalists and Next-Generation Pharmacist® Awards categories are available at nextgenpharmacist.com.

Explore more stories in the categories of: Alumni , Events And Awards

Ready to Get Started

We're here to help you take the next step. We can't wait to welcome you to UHSP.